Sichuan Kelun Pharmaceutical Co Ltd (002422) - Net Assets

Latest as of March 2026: CN¥29.75 Billion CNY ≈ $4.35 Billion USD

Based on the latest financial reports, Sichuan Kelun Pharmaceutical Co Ltd (002422) has net assets worth CN¥29.75 Billion CNY (≈ $4.35 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥41.14 Billion ≈ $6.02 Billion USD) and total liabilities (CN¥11.39 Billion ≈ $1.67 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore how efficiently does Sichuan Kelun Pharmaceutical Co Ltd generate cash to assess how effectively this company generates cash.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥29.75 Billion
% of Total Assets	72.3%
Annual Growth Rate	23.14%
5-Year Change	107.33%
10-Year Change	155.48%
Growth Volatility	77.71

Sichuan Kelun Pharmaceutical Co Ltd - Net Assets Trend (2007–2025)

This chart illustrates how Sichuan Kelun Pharmaceutical Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore Sichuan Kelun Pharmaceutical Co Ltd (002422) investment intensity to see how much of total assets are deployed in long-term investments.

Annual Net Assets for Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual net assets of Sichuan Kelun Pharmaceutical Co Ltd from 2007 to 2025. For live valuation and market cap data, see 002422 stock market capitalisation.

Year	Net Assets	Change
2025-12-31	CN¥29.29 Billion ≈ $4.29 Billion	+9.56%
2024-12-31	CN¥26.74 Billion ≈ $3.91 Billion	+16.17%
2023-12-31	CN¥23.02 Billion ≈ $3.37 Billion	+36.42%
2022-12-31	CN¥16.87 Billion ≈ $2.47 Billion	+19.40%
2021-12-31	CN¥14.13 Billion ≈ $2.07 Billion	+0.90%
2020-12-31	CN¥14.00 Billion ≈ $2.05 Billion	+0.70%
2019-12-31	CN¥13.91 Billion ≈ $2.03 Billion	+7.40%
2018-12-31	CN¥12.95 Billion ≈ $1.89 Billion	+8.06%
2017-12-31	CN¥11.98 Billion ≈ $1.75 Billion	+4.50%
2016-12-31	CN¥11.47 Billion ≈ $1.68 Billion	+2.71%
2015-12-31	CN¥11.16 Billion ≈ $1.63 Billion	+1.76%
2014-12-31	CN¥10.97 Billion ≈ $1.61 Billion	+9.44%
2013-12-31	CN¥10.02 Billion ≈ $1.47 Billion	+10.59%
2012-12-31	CN¥9.06 Billion ≈ $1.33 Billion	+14.29%
2011-12-31	CN¥7.93 Billion ≈ $1.16 Billion	+12.47%
2010-12-31	CN¥7.05 Billion ≈ $1.03 Billion	+346.47%
2009-12-31	CN¥1.58 Billion ≈ $231.12 Million	+32.70%
2008-12-31	CN¥1.19 Billion ≈ $174.17 Million	+72.19%
2007-12-31	CN¥691.22 Million ≈ $101.15 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Sichuan Kelun Pharmaceutical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 2861.7% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	CN¥12.18 Billion	50.28%
Other Components	CN¥12.04 Billion	49.72%
Total Equity	CN¥24.22 Billion	100.00%

Sichuan Kelun Pharmaceutical Co Ltd Competitors by Market Cap

The table below lists competitors of Sichuan Kelun Pharmaceutical Co Ltd ranked by their market capitalization.

Company	Market Cap
ORION CORP.B UNSP.ADR 1/2 F:OFK0	$8.31 Billion
SAINSBURY -J.- ADR/4 NEW F:SUY	$8.31 Billion
SPIE SA PA:SPIE	$8.31 Billion
Builders FirstSource Inc NYSE:BLDR	$8.33 Billion
Bharti Hexacom Ltd NSE:BHARTIHEXA	$8.29 Billion
GETLINK ADR EO-40 F:TNU	$8.29 Billion
Yanzhou Coal Mining Company Limited F:YZC	$8.29 Billion
BlueFocus Communication Group SHE:300058	$8.28 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Sichuan Kelun Pharmaceutical Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 22,479,520,000 to 24,224,470,760, a change of 1,744,950,760 (7.8%).
Net income of 1,701,935,493 contributed positively to equity growth.
Dividend payments of 1,090,707,526 reduced retained earnings.
Other factors increased equity by 1,133,722,793.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥1.70 Billion	+7.03%
Dividends Paid	CN¥1.09 Billion	-4.5%
Other Changes	CN¥1.13 Billion	+4.68%
Total Change	CN¥-	7.76%

Book Value vs Market Value Analysis

This analysis compares Sichuan Kelun Pharmaceutical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.35x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 53.58x to 2.35x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2007-12-31	CN¥0.67	CN¥35.68	x
2008-12-31	CN¥1.10	CN¥35.68	x
2009-12-31	CN¥1.45	CN¥35.68	x
2010-12-31	CN¥5.43	CN¥35.68	x
2011-12-31	CN¥5.43	CN¥35.68	x
2012-12-31	CN¥6.12	CN¥35.68	x
2013-12-31	CN¥6.78	CN¥35.68	x
2014-12-31	CN¥7.50	CN¥35.68	x
2015-12-31	CN¥7.71	CN¥35.68	x
2016-12-31	CN¥7.95	CN¥35.68	x
2017-12-31	CN¥8.20	CN¥35.68	x
2018-12-31	CN¥8.93	CN¥35.68	x
2019-12-31	CN¥9.28	CN¥35.68	x
2020-12-31	CN¥9.44	CN¥35.68	x
2021-12-31	CN¥9.80	CN¥35.68	x
2022-12-31	CN¥10.59	CN¥35.68	x
2023-12-31	CN¥12.74	CN¥35.68	x
2024-12-31	CN¥14.24	CN¥35.68	x
2025-12-31	CN¥15.16	CN¥35.68	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Sichuan Kelun Pharmaceutical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 7.03%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 9.19%
• Asset Turnover: 0.46x
• Equity Multiplier: 1.64x
Recent ROE (7.03%) is below the historical average (12.20%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2007	32.04%	10.73%	1.13x	2.65x	CN¥148.78 Million
2008	26.41%	11.91%	0.98x	2.26x	CN¥192.55 Million
2009	27.29%	13.29%	0.97x	2.13x	CN¥271.04 Million
2010	9.46%	16.42%	0.46x	1.26x	CN¥-37.84 Million
2011	12.33%	18.93%	0.49x	1.34x	CN¥182.43 Million
2012	12.35%	18.48%	0.39x	1.70x	CN¥207.23 Million
2013	11.06%	15.80%	0.38x	1.84x	CN¥103.53 Million
2014	9.33%	12.49%	0.38x	1.97x	CN¥-72.05 Million
2015	5.83%	8.31%	0.34x	2.04x	CN¥-460.73 Million
2016	5.16%	6.83%	0.37x	2.07x	CN¥-548.38 Million
2017	6.34%	6.55%	0.41x	2.37x	CN¥-431.76 Million
2018	9.52%	7.42%	0.56x	2.30x	CN¥-61.77 Million
2019	7.11%	5.32%	0.56x	2.39x	CN¥-380.95 Million
2020	6.14%	5.04%	0.51x	2.37x	CN¥-520.53 Million
2021	7.96%	6.38%	0.55x	2.28x	CN¥-283.13 Million
2022	10.84%	8.96%	0.56x	2.17x	CN¥131.89 Million
2023	12.49%	11.45%	0.59x	1.85x	CN¥488.87 Million
2024	13.06%	13.46%	0.58x	1.66x	CN¥687.94 Million
2025	7.03%	9.19%	0.46x	1.64x	CN¥-720.51 Million

Industry Comparison

This section compares Sichuan Kelun Pharmaceutical Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - General industry.

Industry Context

Industry: Drug Manufacturers - General
Average net assets among peers: $1,421,954,913
Average return on equity (ROE) among peers: 4.45%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Sichuan Kelun Pharmaceutical Co Ltd (002422)	CN¥29.75 Billion	32.04%	0.38x	$8.31 Billion
Zhejiang Int'L Group Co Ltd (000411)	$282.07 Million	6.75%	4.22x	$921.78 Million
Zhejiang Zhenyuan Share Co Ltd (000705)	$34.35 Million	19.93%	2.59x	$340.29 Million
Hunan Jingfeng Pharmaceutical (000908)	$214.83 Million	-46.96%	5.84x	$925.63 Million
Hubei Guangji Pharmaceutical Co Ltd (000952)	$523.19 Million	1.57%	0.74x	$349.60 Million
Yifan Xinfu Pharmaceutical Co Ltd (002019)	$8.71 Billion	4.62%	0.47x	$1.80 Billion
Guangdong Jiaying Pharmaceutical Co Ltd (002198)	$212.62 Million	11.48%	0.15x	$279.98 Million
Chongqing Lummy Pharmaceutical (300006)	$1.13 Billion	5.40%	0.94x	$893.09 Million
Zhejiang Jolly Pharmaceutical Co Ltd (300181)	$165.70 Million	19.06%	0.80x	$1.46 Billion
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357)	$1.53 Billion	18.22%	0.05x	$1.72 Billion

About Sichuan Kelun Pharmaceutical Co Ltd

SHE:002422 China Drug Manufacturers - General

Market Cap

$8.31 Billion

CN¥56.76 Billion CNY

Market Cap Rank

#2600 Global

#332 in China

Share Price

CN¥35.68

Change (1 day)

+1.28%

52-Week Range

CN¥28.83 - CN¥40.70

All Time High

CN¥40.70